Rotigotine Transdermal System
DEFINITION
Rotigotine Transdermal System contains NLT 90.0% and NMT 110.0% of the labeled amount of rotigotine (C19H25NOS).
USP REFERENCE STANDARDS FOR PURCHASE
USP Rotigotine Hydrochloride RSUSP Rotigotine Related Compound C RS
USP Rotigotine Related Compound K RS